Assessment of the Influence of Test Characteristics on the Clinical and Cost Impacts of Methicillin-ResistantStaphylococcus aureusScreening Programs in US Hospitals
| Autor: | Charles Mathews, Natalia Olchanski, William R. Jarvis, Lauren Fusfeld |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Methicillin-Resistant Staphylococcus aureus
Microbiology (medical) medicine.medical_specialty Pediatrics Epidemiology Total cost Cost-Benefit Analysis Staphylococcal infections medicine.disease_cause Polymerase Chain Reaction law.invention law Screening programs Humans Medicine Bacteriological Techniques Cost–benefit analysis business.industry Public health Staphylococcal Infections medicine.disease Methicillin-resistant Staphylococcus aureus Intensive care unit Hospitals United States Test (assessment) Intensive Care Units Models Economic Infectious Diseases Emergency medicine business |
| Zdroj: | Infection Control & Hospital Epidemiology. 32:250-257 |
| ISSN: | 1559-6834 0899-823X 0195-9417 |
| DOI: | 10.1086/658332 |
| Popis: | Objective.To compare the impacts of different methicillin-resistantStaphylococcus aureus(MRSA) screening test options (eg, polymerase chain reaction [PCR], rapid culture) and program characteristics on the clinical outcomes and budget of a typical US hospital.Methods.We developed an Excel-based decision-analytic model, using published literature to calculate and compare hospital costs and MRSA infection rates for PCR- or culture-based MRSA screening and then used multivariate sensitivity analysis to evaluate key variables. Same-day PCR testing for a representative 370-bed teaching hospital in the United States was assessed in different populations (high-risk patients, intensive care unit [ICU] patients, or all patients) and compared with other test options.Results.Different screening program populations (all patients, high-risk patients, ICU patients, or patients with previous MRSA colonization or infection only) represented a potential savings of $12,158-$76,624 per month over no program ($188,618). Analysis of multiple test options in high-risk population screening indicated that same-day PCR testing of high-risk patients resulted in fewer infections over 1,720 patient-days (2.9, compared with 3.5 for culture on selective media and 3.8 for culture on nonselective media) and the lowest total cost ($112,012). The costs of other testing approaches ranged from $113,742 to $123,065. Sensitivity analysis revealed that variations in transmission rate, conversion to infection, prevalence increases, and hospital size are important to determine program impact. Among test characteristics, turnaround time is highly influential.Conclusion.All screening options showed reductions in infection rates and cost impact improvement over no screening program. Among the options, same-day PCR testing for high-risk patients slightly edges out the others in terms of fewest infections and greatest potential cost savings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|